3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Veristat is excited to announce its participation in this year's World Orphan Drug Congress Europe, held in Barcelona, 22 - 25 October 2024
You can find us at Booth 35, where we invite you to stop by and discover more about what makes Veristat a distinguished name in the industry. Our team will share insights and answer any questions you might have. Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
We are pleased to announce that Veristat has been selected as a speaker at the plenary sessions:
You can arrange a meeting by completing the form on the right side of this page. Discover how we can assist you in progressing your upcoming clinical trial or regulatory submission towards a successful outcome or explore our wide range of capabilities.
Website: WODC Congress Europe 2024
Meet with us at WODC Europe 2024 by filling out the form below.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...